24/7 Wall St.

American Express Gets Dueling Calls From BofA and Barclays: Which Side Is Right?

Q1 2026 earnings beat drew a split verdict from Wall Street. Bank of America reiterated its Buy rating and raised its price ...

S&P 500, Nasdaq close at records, boosted by Intel, as investors hope for a restart to U.S.-Iran talks

The broad market index finished up 0.8% at 7,165.08, while the tech-heavy Nasdaq added 1.63% to settle at 24,836.60. Both ...

Barclays Raises its Price Target on Western Digital (WDC) to $405

On April 21, 2026, Barclays analyst Tom O’Malley raised the price target on Western Digital Corporation (NASDAQ:WDC) to $405 ...

Barclays Raises its Price Target on Jazz Pharmaceuticals (JAZZ) to $225

On April 19, 2026, Barclays analyst Etzer Darout raised the price target on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to $225 ...

North American Morning Briefing: Nasdaq Futures Up as Intel Set For Record Gain -2-

Noble Romans Inc (NROM) is expected to report for 4Q. Norfolk Southern Corp (NSC) is expected to report $2.51 for 1Q. Northeast Community Bancorp Inc (NECB) is expected to report $0.75 for 1Q.

Avis Sinks 35%: Short Squeeze Fades as Dilution Risk Takes Center Stage

Shares of Avis Budget Group (NASDAQ:CAR) are cratering in Thursday trading, with the stock last changing hands near $290 ...
InvestorsHub on MSN

Lululemon shares fall after hiring ex-Nike executive Heidi O’Neill as CEO

Lululemon Athletica (NASDAQ:LULU) stock dropped करीब 4% in premarket trading on Thursday after the company announced the ...
InvestorsHub on MSN

Tesla shares turn lower as higher capex overshadows Q1 beat

Tesla (NASDAQ:TSLA) stock fell in premarket trading on Thursday after the company significantly increased its capital ...

North American Morning Briefing: Markets Drop From Record Highs Amid Fresh Iran Tensions -2-

Air War in Iran Gives Way to Crippling Stalemate in Hormuz ISLAMABAD, Pakistan-The conflict with Iran has entered a damaging new phase-a crippling limbo between war and peace that leaves the Strait of ...

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

(Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced the pricing of its previously announced underwritten public ...
Honolulu Star-Advertiser

S&P, Nasdaq close at records on Iran ceasefire extension

NEW YORK >> U.S. stocks climbed today to send the S&P 500 and Nasdaq to closing records, after President Donald Trump ...

Altimmune Announces Proposed Underwritten Public Offering of Securities

Altimmune intends to use the net proceeds from this proposed offering to fund its upcoming Phase 3 trial in metabolic dysfunction-associated steatohepatitis (MASH), as well as for working capital and ...